ELAPRASE
Active substance: idursulfase
SOLUTION, CONCENTRATE · IDURSULFASE 6 mg/3mL
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- IDURSULFASE · 6 mg/3mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209d-83cf-74e9-a312-7848ab10c053;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 54092-700
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 54092-700 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 54092-700 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 54092-700 · Verified 2026-10-09 · open in source